Quadira Biosciences Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Quadira Biosciences General Information
Description
Developer of 3D cell technology intended to replicate human tissue for reliable testing and characterization of antibodies without animal testing. The company allows the testing and characterization in terms of efficacy of antibodies in 3D-cell cultures, also known as organoids, which are similar to animal or human tissue, thereby enabling professionals to reduce or even eliminate animal testing and accelerate product development significantly.
Contact Information
Website
www.quadirabiosciences.comCorporate Office
- Weissensteinstrasse 81
- 4500 Solothurn
- Switzerland
Corporate Office
- Weissensteinstrasse 81
- 4500 Solothurn
- Switzerland
Quadira Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quadira Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quadira Biosciences FAQs
-
When was Quadira Biosciences founded?
Quadira Biosciences was founded in 2021.
-
Where is Quadira Biosciences headquartered?
Quadira Biosciences is headquartered in Solothurn, Switzerland.
-
What industry is Quadira Biosciences in?
Quadira Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Quadira Biosciences a private or public company?
Quadira Biosciences is a Private company.
-
What is Quadira Biosciences’s current revenue?
The current revenue for Quadira Biosciences is .
-
Who are Quadira Biosciences’s investors?
Xlife Sciences has invested in Quadira Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process